当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析

盟科药业-U

(688373)

  

流通市值:21.19亿  总市值:37.96亿
流通股本:3.66亿   总股本:6.56亿

盟科药业-U(688373)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2024年年度实现净利润-4.41亿元,每股收益-0.67元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2024年年度最新股东权益43896.38万元,未分配利润-180469.15万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2024年年度最新总资产84912.87万元,负债41016.49万元。

利润表
报告期2024-12-312024-09-302024-06-302024-03-31
营业总收入130,272,762.0197,562,309.8360,738,238.4533,016,131.56
营业总成本581,598,318.57394,736,146.75267,528,409.42140,526,292.61
营业利润-434,488,730.84-285,121,099.87-196,540,889.36-102,130,819.86
利润总额-434,511,616.97-285,134,839.3-196,546,693.17-102,136,623.67
净利润-440,721,217.09-291,296,145.99-201,304,246.81-102,136,623.67
其他综合收益6,175,113.781,623,228.554,298,551.74673,642.43
综合收益总额-434,546,103.31-289,672,917.44-197,005,695.07-101,462,981.24
资产负债表
报告期2024-12-312024-09-302024-06-302024-03-31
流动资产合计748,661,957.2869,192,299.77896,380,052.57992,871,282.96
非流动资产合计100,466,702.42101,557,316.22106,470,184.99110,313,711.58
资产总计849,128,659.62970,749,615.991,002,850,237.561,103,184,994.54
流动负债合计212,296,583.22128,027,426.86108,421,851.35137,975,631.81
非流动负债合计197,868,324.69275,068,895.66239,800,368.3223,399,200.35
负债合计410,164,907.91403,096,322.52348,222,219.65361,374,832.16
归属于母公司股东权益合计438,963,751.71567,653,293.47654,628,017.91741,810,162.38
股东权益合计438,963,751.71567,653,293.47654,628,017.91741,810,162.38
负债和股东权益合计849,128,659.62970,749,615.991,002,850,237.561,103,184,994.54
现金流量表
报告期2024-12-312024-09-302024-06-302024-03-31
经营活动现金流入小计140,148,380.61102,006,625.466,681,002.4233,600,922.07
经营活动现金流出小计587,329,115.94395,492,556.02295,704,839.52134,333,713.86
经营活动产生的现金流量净额-447,180,735.33-293,485,930.62-229,023,837.1-100,732,791.79
投资活动现金流入小计3,007,544,042.271,904,622,936.41,250,505,656.61646,070,755.08
投资活动现金流出小计2,492,745,819.281,565,134,550.131,052,366,049.88488,237,950.99
投资活动产生的现金流量净额514,798,222.99339,488,386.27198,139,606.73157,832,804.09
筹资活动现金流入小计106,977,035100,000,00060,000,00030,000,000
筹资活动现金流出小计38,882,257.2626,070,254.5117,066,631.196,942,436.05
筹资活动产生的现金流量净额68,094,777.7473,929,745.4942,933,368.8123,057,563.95
汇率变动对现金及现金等价物的影响143,372.07-3,394,068.68-1,063,665.66-972,581.97
现金及现金等价物净增加额135,855,637.47116,538,132.4610,985,472.7879,184,994.28
期末现金及现金等价物余额273,332,290.62254,014,785.61148,462,125.93216,661,647.43
最新报告期:2025-03-20
研究机构分析师预测每股收益(元)更新日
2024年2025年2026年
光大证券叶思奥,王明瑞-0.58-0.44-0.292025-03-20
TOP↑